Gene therapy for unresectable hepatocellular carcinoma using recombinant human adenovirus type 5

New Data Supporting Modified RECIST (mRECIST) for Hepatocellular Carcinoma

(2013) R. Lencioni   CLINICAL CANCER RESEARCH

Long-term survival after surgical resection for huge hepatocellular carcinoma: Comparison with transarterial chemoembolization after propensity score matching

(2013) Yang Won Min et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Cytokine-induced Killer Cells in Combination With Transcatheter Arterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Patients

(2013) Zhi-Mei Huang et al.   JOURNAL OF IMMUNOTHERAPY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Transarterial Chemoembolization With Cisplatin as Second-Line Treatment for Hepatocellular Carcinoma Unresponsive to Chemoembolization With Epirubicin-Lipiodol Emulsion

(2011) Noboru Maeda et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction

(2010) Thomas W. Rice et al.   ANNALS OF SURGICAL ONCOLOGY

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization

(2010) J.-L. Raoul et al.   CANCER TREATMENT REVIEWS

Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   JNCI-Journal of the National Cancer Institute

Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan

(2007) Masatoshi Makuuchi et al.   HEPATOLOGY RESEARCH